Human Genome Sciences' IPO

Human Genome Sciences raised a round of funding on , . Investors include Public.

Human Genome Sciences is a development stage company that was formed to develop and commercialize therapeutically enhanced proprietary biopharmaceuticals with the aim of offering significant reduction…

Articles about Human Genome Sciences' IPO: